Related Experiment Video

Updated: Jan 8, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

875

Changes in Eating Behaviour During Treatment With Obesity Medications

Ming Chuen Chong1, Tak Ying Louise Ko1, Philippus L le Roux1

  • 1Diabetes Complications Research Centre, University College Dublin, Dublin, Ireland.

Clinical Obesity
|December 20, 2025
PubMed

Insights

Pharmacological obesity treatments effectively reduce appetite and food cravings. Patients experience weight loss and maintenance as a spectrum, with portion control being a key long-term behavior.

Area of Science:

  • Obesity research
  • Behavioral science
  • Pharmacological interventions

Background:

  • Obesity is a complex, chronic disease influenced by multiple factors.
  • Pharmacological therapies aid weight loss but long-term effects on eating behaviors are unclear.

Purpose of the Study:

  • To explore patient experiences with weight loss medications and eating behaviors during dynamic and stable phases.
  • To understand the transition from weight loss to weight maintenance.

Main Methods:

  • Qualitative study utilizing 31 semi-structured interviews.
  • Thematic analysis of interviews focusing on hunger, fullness, food thoughts, portion size, and palatability.

Main Results:

  • Dynamic phase: profound appetite suppression, early fullness, reduced food noise, smaller portions.
  • Portion control is a persistent behavioral change across phases.
  • Long-term goals shift from weight loss to maintenance; medication efficacy concerns arise in the stable phase.

Conclusions:

  • Weight management is a spectrum, not a dichotomy.
  • Patient-centered insights can inform clinical practice, policy, and future research on obesity pharmacotherapy.
Keywords:
dynamic phasefood noiseobesity pharmacotherapystable phase

More Related Videos

Control of Eating Behavior Using a Novel Feedback System04:48

Control of Eating Behavior Using a Novel Feedback System

Published on: May 8, 2018

11.4K
Self-Administration of Drugs in Mouse Models of Feeding and Obesity03:37

Self-Administration of Drugs in Mouse Models of Feeding and Obesity

Published on: June 8, 2021

5.1K

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
221
Binge Eating Disorders01:23

Binge Eating Disorders

Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
402
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
159
Bulimia Nervosa01:30

Bulimia Nervosa

Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
641
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
198
Regulation of Food Intake01:30

Regulation of Food Intake

Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
2.2K